Aurora Cannabis May Miss Debt Covenants, Analysts Warn
- Stock downgraded by two analysts amid balance-sheet risks
- Company has $400m at-the-market equity program it can tap
This article is for subscribers only.
The chorus of voices warning of risks to Aurora Cannabis Inc.’s balance sheet is growing louder.
With a C$360 million loan coming due in August 2021, at least three analysts have cautioned that the pot company may be unable to meet the covenants on that debt.